Page last updated: 2024-11-04

rofecoxib and Dementia

rofecoxib has been researched along with Dementia in 3 studies

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the effectiveness and adverse effects of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) for the primary or secondary prevention of dementia."9.05Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia. ( Devane, D; Jordan, F; Kelly, JP; McGuinness, B; Murphy, K; Passmore, P; Quinn, TJ; Tudur Smith, C, 2020)
"To evaluate the effectiveness and adverse effects of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) for the primary or secondary prevention of dementia."5.05Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia. ( Devane, D; Jordan, F; Kelly, JP; McGuinness, B; Murphy, K; Passmore, P; Quinn, TJ; Tudur Smith, C, 2020)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Jordan, F1
Quinn, TJ1
McGuinness, B1
Passmore, P1
Kelly, JP1
Tudur Smith, C1
Murphy, K1
Devane, D1
Thal, LJ1
Ferris, SH1
Kirby, L1
Block, GA1
Lines, CR1
Yuen, E1
Assaid, C1
Nessly, ML1
Norman, BA1
Baranak, CC1
Reines, SA1

Reviews

1 review available for rofecoxib and Dementia

ArticleYear
Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia.
    The Cochrane database of systematic reviews, 2020, 04-30, Volume: 4

    Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Age

2020

Trials

1 trial available for rofecoxib and Dementia

ArticleYear
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:6

    Topics: Aged; Cognition Disorders; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors;

2005

Other Studies

1 other study available for rofecoxib and Dementia

ArticleYear
Top 10 health stories of 2004.
    Harvard health letter, 2004, Volume: 30, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antidepressive Agents; Antineopla

2004